kabutan

Noile-Immune Biotech, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.

Fri Feb 13, 2026 4:05 pm JST Earnings

4893 Noile-Immune Biotech Inc. 【J-GAAP】

Earnings Report

Noile-Immune Biotech Inc. <4893> [TSE Growth] announced its financial results after the market closed on February 13th (16:05). The ordinary loss (non-consolidated) for the fiscal year ended December 2025 was loss of 791 million yen, a reduction in the deficit compared to loss of 962 million yen in the previous term. This marks the sixth consecutive term of losses. Furthermore, the company did not disclose the performance outlook for the fiscal year ending December 2026.

In the most recent three-month period, from October to December (4Q), the ordinary loss expanded to loss of 189 million yen (compared to a loss of 177 million yen in the same period last year).

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 316 -775 -1,127 -1,130 -27.3 0 Feb 13, 2024 J-GAAP
Dec, 2024 7 -1,069 -962 -964 -22.3 0 Feb 14, 2025 J-GAAP
Dec, 2025 5 -797 -791 -793 -18.3 0 Feb 13, 2026 J-GAAP
YoY -28.6% +25.4% +17.8% +17.7% +17.7%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance 5 -812 -806 -809 -18.7 0 Nov 13, 2025 J-GAAP
Dec, 2025 Results 5 -797 -791 -793 -18.3 0 Feb 13, 2026 J-GAAP
Revision Rate 0.0% +1.8% +1.9% +2.0% +1.9%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 4 -412 -410 -411 -9.5 0 Aug 8, 2025 J-GAAP
Jan - Jun, 2026 Guidance ー ー ー ー － 0 Feb 13, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 7 -1,069 -962 -964 -22.3 0 Feb 14, 2025 J-GAAP
Dec, 2025 5 -797 -791 -793 -18.3 0 Feb 13, 2026 J-GAAP
Dec, 2026 Guidance ー ー ー ー － 0 Feb 13, 2026 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 2 -177 -177 -177 -4.1 -8,850.0 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 2 -241 -239 -240 -5.6 -12,050.0 May 12, 2025 J-GAAP
Apr - Jun, 2025 2 -171 -171 -171 -4.0 -8,550.0 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 1 -196 -192 -194 -4.5 -19,600.0 Nov 13, 2025 J-GAAP
Oct - Dec, 2025 0 -189 -189 -188 -4.4 -Inf Feb 13, 2026 J-GAAP
YoY － -6.8% -6.8% -6.2% -6.4%

Related Articles